4.6 Article

Id2-Mediated Inhibition of E2A Represses Memory CD8+ T Cell Differentiation

期刊

JOURNAL OF IMMUNOLOGY
卷 190, 期 9, 页码 4585-4594

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.1300099

关键词

-

资金

  1. National Health and Medical Research Council of Australia
  2. Wellcome Trust
  3. Viertel Foundation
  4. Howard Hughes Medical Institute
  5. Australian Research Council
  6. Boehringer Ingelheim
  7. Genome Research in Austria initiative
  8. Bundesminsterium fur Bildung und Wissenschaft
  9. Victorian State Government
  10. Australian Government National Health and Medical Research Council Independent Research Institute Infrastructure Support Scheme

向作者/读者索取更多资源

The transcription factor inhibitor of DNA binding (Id) 2 modulates T cell fate decisions, but the molecular mechanism underpinning this regulation is unclear. In this study we show that loss of Id2 cripples effector differentiation and instead programs CD8(+) T cells to adopt a memory fate with increased Eomesodermin and Tcf7 expression. We demonstrate that Id2 restrains CD8(+) T cell memory differentiation by inhibiting E2A-mediated direct activation of Tcf7 and that Id2 expression level mirrors T cell memory recall capacity. As a result of the defective effector differentiation, Id2-deficient CD8(+) T cells fail to induce sufficient Tbx21 expression to generate short-lived effector CD8(+) T cells. Our findings reveal that the Id2/E2A axis orchestrates T cell differentiation through the induction or repression of downstream transcription factors essential for effector and memory T cell differentiation. The Journal of Immunology, 2013, 190: 4585-4594.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据